Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2222-2230
Published online before print July 27, 2006, doi: 10.1161/01.ATV.0000238356.20565.92
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/10/2222    most recent
01.ATV.0000238356.20565.92v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Philippova, M.
Right arrow Articles by Resink, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Philippova, M.
Right arrow Articles by Resink, T.
Related Collections
Right arrow Angiogenesis
Right arrow Other arteriosclerosis
Right arrow Other Vascular biology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2222.)
© 2006 American Heart Association, Inc.


Vascular Biology

Atypical GPI-Anchored T-Cadherin Stimulates Angiogenesis In Vitro and In Vivo

Maria Philippova; Andrea Banfi; Danila Ivanov; Roberto Gianni-Barrera; Roy Allenspach; Paul Erne; Thérèse Resink

From the Cardiovascular Signalling Group (M.P., D.I., R.A., T.R.), Department of Research, and Cell and Gene Therapy Group (A.B.), Departments of Surgery and of Research, Basel University Hospital, and Division of Cardiology (P.E.), Kantonsspital Luzern, Switzerland.

Correspondence to Dr Maria Philippova, Cardiovascular Signalling, ZLF 316, Basel University Hospital, Hebelstrasse 20, CH-4031 Basel, Switzerland. E-mail maria.filippova{at}unibas.ch

Objective— T-cadherin (T-cad) is an atypical GPI-anchored member of the cadherin superfamily. In vascular tissue, T-cad expression is increased during atherosclerosis, restenosis, and tumor neovascularization. In vitro, overexpression and/or homophilic ligation of T-cad on endothelial cells (ECs) facilitates migration, proliferation, and survival. This study investigated T-cad effects on angiogenesis.

Methods and Results— In vitro, T-cad homophilic ligation induced arrangement of ECs into a capillary-like network in a 2-dimensional model of EC differentiation and stimulated in-gel endothelial sprout outgrowth in an EC spheroid model and a modified Nicosia tissue assay. Sprouting from spheroids composed of adenoviral-infected T-cad overexpressing ECs or T-cad siRNA transfected ECs were significantly increased or reduced, respectively. In vivo, T-cad potentiated VEGF effects on neovascularization in a model of myoblast-mediated gene transfer to mouse skeletal muscle; vessel caliber after co-delivery of T-cad and VEGF was significantly greater than after delivery of VEGF alone.

Conclusions— We unequivocally identify T-cad as a novel modulator of angiogenesis and suggest that this molecule can be exploited as a target for modulation of therapeutic angiogenesis, as well as for prevention of pathological conditions associated with abnormal neovascularization.

This study demonstrates that GPI-anchored T-cadherin stimulates angiogenesis in 2-dimensional model of endothelial differentiation, in 3-dimensional endothelial spheroid, and Nicosia tissue assays in vitro. In vivo, T-cad potentiates VEGF effects on neovascularization in mouse skeletal muscle. We conclude that T-cad is a novel modulator of angiogenesis.


Key Words: angiogenesis • cadherin • endothelial cell differentiation • VEGF




This article has been cited by other articles:


Home page
FASEB J.Home page
M. B. Joshi, E. Kyriakakis, D. Pfaff, K. Rupp, M. Philippova, P. Erne, and T. J. Resink
Extracellular cadherin repeat domains EC1 and EC5 of T-cadherin are essential for its ability to stimulate angiogenic behavior of endothelial cells
FASEB J, November 1, 2009; 23(11): 4011 - 4021.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Dames, E. Bang, D. Haussinger, T. Ahrens, J. Engel, and S. Grzesiek
Insights into the Low Adhesive Capacity of Human T-cadherin from the NMR Structure of Its N-terminal Extracellular Domain
J. Biol. Chem., August 22, 2008; 283(34): 23485 - 23495.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Philippova, D. Ivanov, M. B. Joshi, E. Kyriakakis, K. Rupp, T. Afonyushkin, V. Bochkov, P. Erne, and T. J. Resink
Identification of Proteins Associating with Glycosylphosphatidylinositol- Anchored T-Cadherin on the Surface of Vascular Endothelial Cells: Role for Grp78/BiP in T-Cadherin-Dependent Cell Survival
Mol. Cell. Biol., June 15, 2008; 28(12): 4004 - 4017.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. B. Joshi, D. Ivanov, M. Philippova, P. Erne, and T. J. Resink
Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3{beta} in endothelial cells
FASEB J, October 1, 2007; 21(12): 3083 - 3095.
[Abstract] [Full Text] [PDF]